Annual EBITDA:
-$133.99M+$71.12M(+34.68%)Summary
- As of today, TXG annual EBITDA is -$133.99 million, with the most recent change of +$71.12 million (+34.68%) on December 31, 2024.
- During the last 3 years, TXG annual EBITDA has fallen by -$109.39 million (-444.78%).
- TXG annual EBITDA is now -883.40% below its all-time high of -$13.63 million, reached on December 31, 2017.
Performance
TXG EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$19.99M-$19.07M(-2065.87%)Summary
- As of today, TXG quarterly EBITDA is -$19.99 million, with the most recent change of -$19.07 million (-2065.87%) on September 30, 2025.
- Over the past year, TXG quarterly EBITDA has increased by +$10.74 million (+34.96%).
- TXG quarterly EBITDA is now -753.51% below its all-time high of $3.06 million, reached on December 31, 2020.
Performance
TXG Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$98.54M+$10.74M(+9.83%)Summary
- As of today, TXG TTM EBITDA is -$98.54 million, with the most recent change of +$10.74 million (+9.83%) on September 30, 2025.
- Over the past year, TXG TTM EBITDA has increased by +$34.84 million (+26.12%).
- TXG TTM EBITDA is now -652.59% below its all-time high of -$13.09 million, reached on September 30, 2021.
Performance
TXG TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TXG EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +34.7% | +35.0% | +26.1% |
| 3Y3 Years | -444.8% | +37.3% | +23.5% |
| 5Y5 Years | -541.5% | -3.0% | -30.5% |
TXG EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -444.8% | +34.7% | -2065.9% | +61.2% | at high | +40.4% |
| 5Y | 5-Year | -541.5% | +73.9% | -753.5% | +63.4% | -652.6% | +40.4% |
| All-Time | All-Time | -883.4% | +73.9% | -753.5% | +73.0% | -652.6% | +40.4% |
TXG EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$19.99M(-2065.9%) | -$98.54M(+9.8%) |
| Jun 2025 | - | -$923.00K(+97.6%) | -$109.29M(+21.5%) |
| Mar 2025 | - | -$38.61M(+1.0%) | -$139.20M(+6.3%) |
| Dec 2024 | -$133.99M(+34.7%) | -$39.02M(-26.9%) | -$148.49M(-11.3%) |
| Sep 2024 | - | -$30.73M(+0.3%) | -$133.38M(+7.8%) |
| Jun 2024 | - | -$30.84M(+35.6%) | -$144.62M(+12.5%) |
| Mar 2024 | - | -$47.90M(-100.4%) | -$165.26M(-2.8%) |
| Dec 2023 | -$205.11M(-59.6%) | -$23.90M(+43.0%) | -$160.73M(-6.1%) |
| Sep 2023 | - | -$41.97M(+18.5%) | -$151.45M(-7.1%) |
| Jun 2023 | - | -$51.48M(-18.7%) | -$141.36M(+2.2%) |
| Mar 2023 | - | -$43.37M(-196.6%) | -$144.55M(-7.1%) |
| Dec 2022 | -$128.49M(-422.4%) | -$14.62M(+54.1%) | -$134.94M(-4.7%) |
| Sep 2022 | - | -$31.88M(+41.7%) | -$128.82M(-22.1%) |
| Jun 2022 | - | -$54.67M(-61.9%) | -$105.54M(-92.4%) |
| Mar 2022 | - | -$33.76M(-296.9%) | -$54.86M(-122.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$24.59M(+95.2%) | -$8.51M(+1.1%) | -$24.66M(-88.3%) |
| Sep 2021 | - | -$8.60M(-115.6%) | -$13.09M(+45.2%) |
| Jun 2021 | - | -$3.99M(-12.2%) | -$23.90M(+56.2%) |
| Mar 2021 | - | -$3.56M(-216.3%) | -$54.54M(+19.1%) |
| Dec 2020 | -$513.77M(-2359.7%) | $3.06M(+115.8%) | -$67.37M(+10.8%) |
| Sep 2020 | - | -$19.41M(+44.0%) | -$75.53M(-19.6%) |
| Jun 2020 | - | -$34.63M(-111.2%) | -$63.17M(-68.4%) |
| Mar 2020 | - | -$16.39M(-221.9%) | -$37.51M(-63.1%) |
| Dec 2019 | -$20.89M(+80.3%) | -$5.09M(+27.8%) | -$23.00M(+74.9%) |
| Sep 2019 | - | -$7.05M(+21.4%) | -$91.81M(+6.9%) |
| Jun 2019 | - | -$8.97M(-376.7%) | -$98.58M(-10.0%) |
| Mar 2019 | - | -$1.88M(+97.5%) | -$89.61M(-2.1%) |
| Dec 2018 | -$106.08M(-678.6%) | -$73.90M(-434.7%) | -$87.73M(-534.7%) |
| Sep 2018 | - | -$13.82M | -$13.82M |
| Dec 2017 | -$13.63M | - | - |
FAQ
- What is 10x Genomics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. annual EBITDA year-on-year change?
- What is 10x Genomics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. quarterly EBITDA year-on-year change?
- What is 10x Genomics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. TTM EBITDA year-on-year change?
What is 10x Genomics, Inc. annual EBITDA?
The current annual EBITDA of TXG is -$133.99M
What is the all-time high annual EBITDA for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high annual EBITDA is -$13.63M
What is 10x Genomics, Inc. annual EBITDA year-on-year change?
Over the past year, TXG annual EBITDA has changed by +$71.12M (+34.68%)
What is 10x Genomics, Inc. quarterly EBITDA?
The current quarterly EBITDA of TXG is -$19.99M
What is the all-time high quarterly EBITDA for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high quarterly EBITDA is $3.06M
What is 10x Genomics, Inc. quarterly EBITDA year-on-year change?
Over the past year, TXG quarterly EBITDA has changed by +$10.74M (+34.96%)
What is 10x Genomics, Inc. TTM EBITDA?
The current TTM EBITDA of TXG is -$98.54M
What is the all-time high TTM EBITDA for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high TTM EBITDA is -$13.09M
What is 10x Genomics, Inc. TTM EBITDA year-on-year change?
Over the past year, TXG TTM EBITDA has changed by +$34.84M (+26.12%)